Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.6%

8 terminated/withdrawn out of 122 trials

Success Rate

90.5%

+3.9% vs industry average

Late-Stage Pipeline

5%

6 trials in Phase 3/4

Results Transparency

4%

3 of 76 completed trials have results

Key Signals

17 recruiting3 with results6 terminated

Enrollment Performance

Analytics

N/A
37(38.9%)
Phase 2
35(36.8%)
Phase 1
17(17.9%)
Phase 3
5(5.3%)
Phase 4
1(1.1%)
95Total
N/A(37)
Phase 2(35)
Phase 1(17)
Phase 3(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (122)

Showing 20 of 122 trials
NCT05196087Recruiting

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Role: collaborator

NCT04224974Not ApplicableRecruiting

Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia

Role: collaborator

NCT07801235Not ApplicableRecruiting

HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)

Role: collaborator

NCT07524114Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Role: collaborator

NCT00715611Phase 2Active Not Recruiting

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Role: collaborator

NCT01505400Active Not Recruiting

Integrated Molecular Profiling in Advanced Cancers Trial

Role: collaborator

NCT02724488Completed

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Role: collaborator

NCT00890006Not ApplicableActive Not Recruiting

Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Role: collaborator

NCT00913939Not ApplicableRecruiting

High-Dose-Rate Brachytherapy

Role: collaborator

NCT01802242Not ApplicableCompleted

Tumor TARGET Prostate Cancer

Role: collaborator

NCT06363266Not ApplicableRecruiting

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

Role: collaborator

NCT04599309Active Not Recruiting

Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma

Role: collaborator

NCT05403177Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Role: collaborator

NCT02906943Recruiting

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Role: collaborator

NCT01702831Phase 2Completed

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Role: collaborator

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT01803542Phase 2Recruiting

Stereotactic Radiotherapy (SBRT) of Lung Metastasis

Role: collaborator

NCT01999062Not ApplicableCompleted

Automated Breast Radiation Therapy Using an MR-Guided Process

Role: collaborator

NCT00160979Phase 2Completed

Transrectal Tumour Oxygen - US Army

Role: collaborator

NCT01761929Phase 2Completed

5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

Role: collaborator